Mehryar Habibi Roudkenar

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 11

Top Venues

Medical oncology (Northwood, London, England)

Stem cell reviews and reports

Molecular biology reports

Advanced pharmaceutical bulletin

Guilan University of Medical Sciences,

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Guilan University of Medical Sciences, Oct 28 2016

Iran

Professor :: Medical Biotechnology

Publications

Mehdi Rabiee Valashedi, Chia Bamshad, Nima Najafi-Ghalehlou, Amirsadegh Nikoo, Kazuo Tomita, Yoshikazu Kuwahara, Tomoaki Sato, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar
Non-coding RNAs in ferroptotic cancer cell death pathway: meet the new masters. Human cell 35 (4) (2022)
Saghi Jani Kargar Moghaddam, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar, Shadman Nemati, Nima Najafi-Ghalehlou, Toofan Pakzad, Masoud Hamidi
Study of Three Potential Diagnostic Biomarkers in Nasopharyngeal Carcinoma Samples from Guilan, North of Iran. International archives of otorhinolaryngology 27 (3) (2022)
Hamed Hosseinalizadeh, Mehrdad Mahmoodpour, Ali Akbar Samadani, Mehryar Habibi Roudkenar
The immunosuppressive role of indoleamine 2, 3-dioxygenase in glioblastoma: mechanism of action and immunotherapeutic strategies. Medical oncology (Northwood, London, England) 39 (9) (2022)
Sahar Evazi Bakhshi, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar, Shima Shekarchi, Mohammad Hadi Bahadori
CRISPR/Cas9-mediated knockout of HO-1 decreased the proliferation and migration of T47D cells and increased cisplatin-induced apoptosis: an in vitro study. Medical oncology (Northwood, London, England) 39 (11) (2022)
Nima Najafi-Ghalehlou, Alireza Feizkhah, Mohammadreza Mobayen, Zahra Pourmohammadi-Bejarpasi, Shima Shekarchi, Amaneh Mohammadi Roushandeh, Mehryar Habibi Roudkenar
Plumping up a Cushion of Human Biowaste in Regenerative Medicine: Novel Insights into a State-of-the-Art Reserve Arsenal. Stem cell reviews and reports 18 (8) (2022)
Chia Bamshad, Nima Najafi-Ghalehlou, Zahra Pourmohammadi-Bejarpasi, Kazuo Tomita, Yoshikazu Kuwahara, Tomoaki Sato, Alireza Feizkhah, Amaneh Mohammadi Roushnadeh, Mehryar Habibi Roudkenar
Mitochondria: how eminent in ageing and neurodegenerative disorders? Human cell (2022)
Zahra Alijani-Ghazyani, Reza Sabzevari, Amaneh Mohammadi Roushandeh, Ali Jahanian-Najafabadi, Fatemeh Amiri, Mehryar Habibi Roudkenar
Transplantation of Umbilical Cord-Derived Mesenchymal Stem Cells Overexpressing Lipocalin 2 Ameliorates Ischemia-Induced Injury and Reduces Apoptotic Death in a Rat Acute Myocardial Infarction Model. Stem cell reviews and reports 16 (5) (2021)
Zahra Pourmohammadi-Bejarpasi, Reza Sabzevari, Amaneh Mohammadi Roushandeh, Ammar Ebrahimi, Mohammadreza Mobayen, Ali Jahanian-Najafabadi, Abbas Darjani, Mehryar Habibi Roudkenar
Combination Therapy of Metadichol Nanogel and Lipocalin-2 Engineered Mesenchymal Stem Cells Improve Wound Healing in Rat Model of Excision Injury. Advanced pharmaceutical bulletin 12 (3) (2021)
Fatemeh Amiri, Ali Asghar Talebi, Marzie Bahadori, Mehryar Habibi Roudkenar
Co-culture of mesenchymal stem cell spheres with hematopoietic stem cells under hypoxia: a cost-effective method to maintain self-renewal and homing marker expression. Molecular biology reports (2021)
Amaneh Mohammadi Roushandeh, Kazuo Tomita, Yoshikazu Kuwahara, Ali Jahanian-Najafabadi, Kento Igarashi, Mehryar Habibi Roudkenar, Tomoaki Sato
Transfer of healthy fibroblast-derived mitochondria to HeLa ρ0 and SAS ρ0 cells recovers the proliferation capabilities of these cancer cells under conventional culture medium, but increase their sensitivity to cisplatin-induced apoptotic death. Molecular biology reports 47 (6) (2020)
Hamed Bashiri, Fatemeh Amiri, Ali Hosseini, Masoud Hamidi, Amaneh Mohammadi Roushandeh, Yoshikazu Kuwahara, Mohammad Ali Jalili, Mehryar Habibi Roudkenar
Dual Preconditioning: A Novel Strategy to Withstand Mesenchymal Stem Cells against Harsh Microenvironments. Advanced pharmaceutical bulletin 8 (3) (2018)

Mehryar Habibi Roudkenar.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Mehryar Habibi Roudkenar